Berenberg maintains $90 target on Lam Research stock

Published 24/04/2025, 11:18
Berenberg maintains $90 target on Lam Research stock

On Thursday, Berenberg reiterated its Buy rating on Lam Research (NASDAQ:LRCX), an $85.66 billion market cap semiconductor equipment manufacturer, with a steadfast $90.00 price target. According to InvestingPro data, the company maintains a strong Buy consensus among analysts, with targets ranging from $70 to $125. In light of the company’s third-quarter results, which showed a 13.2% year-over-year revenue growth, the firm addressed the ongoing concerns regarding potential impacts of recent tariff changes on the electronics end-market demand and global semiconductor equipment capital expenditures (capex). Despite these concerns, Lam Research confirmed that it is keeping its wafer fabrication equipment (WFE) capex estimates unchanged for 2025, anticipating to remain within the $100 billion range.

The company, in its earnings call, expressed confidence in its growth prospects, citing a strong position to outperform the market due to its significant exposure to technology migrations among chipmakers. With a PEG ratio of 0.74, InvestingPro analysis suggests the stock is trading at an attractive valuation relative to its growth potential. Lam Research emphasized that their customer spending plans have not been altered since the initiation of the tariff changes in April. The company underlined that technology migrations are typically part of a multi-year investment strategy for chipmakers, who invest counter-cyclically to stay competitive.

The sentiment shared by Lam Research echoes comments made by TSMC during its first-quarter results the previous week, confirming that it would not be modifying its capex plans for the year 2025. However, Berenberg highlighted that despite the current stability, there remain uncertainties in the semiconductor market for the second half of 2025. The firm pointed out that the semiconductor tariff situation is still ambiguous, and potential U.S. restrictions on China’s access to AI chips could lead to a demand downturn that the market may not fully anticipate at this moment. Nevertheless, Lam Research maintains a strong financial health score according to InvestingPro, with a healthy current ratio of 2.54 and impressive return on equity of 50%, suggesting resilience to market uncertainties.

In other recent news, Lam Research Corporation has reported its Q1 2025 earnings, surpassing expectations with an earnings per share (EPS) of $1.04 and revenue totaling $4.72 billion, both exceeding forecasts. The company achieved a record gross margin of 49% since its merger with Novelis, highlighting strong operational efficiency. For the upcoming Q2 2025, Lam Research has projected revenue of $5 billion with a gross margin of 49.5%. In addition, Evercore ISI has raised Lam Research’s stock price target from $95 to $99, maintaining an Outperform rating, due to the company’s consistent performance and positive future outlook. The firm emphasized Lam Research’s potential to benefit from technological advancements in the semiconductor sector, particularly in areas like NAND enterprise SSDs and Gate-All-Around transistors. These developments reflect Lam Research’s strategic focus on growth and innovation, supported by increased R&D spending. Investors are advised to note these recent developments in assessing the company’s position within the evolving semiconductor industry.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.